MONTERA, ROBERTO
 Distribuzione geografica
Continente #
AS - Asia 4.308
NA - Nord America 908
EU - Europa 380
SA - Sud America 138
AF - Africa 16
OC - Oceania 14
Totale 5.764
Nazione #
SG - Singapore 3.504
US - Stati Uniti d'America 848
CN - Cina 405
HK - Hong Kong 236
GB - Regno Unito 110
IT - Italia 104
BR - Brasile 94
VN - Vietnam 80
DE - Germania 56
CA - Canada 40
IN - India 28
CZ - Repubblica Ceca 21
AR - Argentina 18
MX - Messico 15
NL - Olanda 15
AU - Australia 13
FR - Francia 10
JP - Giappone 10
TR - Turchia 8
CL - Cile 7
EE - Estonia 7
FI - Finlandia 7
PL - Polonia 7
SE - Svezia 7
ZA - Sudafrica 7
BD - Bangladesh 6
ID - Indonesia 6
UA - Ucraina 6
EC - Ecuador 5
ES - Italia 4
RS - Serbia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
IQ - Iraq 3
LT - Lituania 3
NO - Norvegia 3
PY - Paraguay 3
RU - Federazione Russa 3
SA - Arabia Saudita 3
TW - Taiwan 3
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EG - Egitto 2
IL - Israele 2
LB - Libano 2
MK - Macedonia 2
PE - Perù 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BG - Bulgaria 1
BY - Bielorussia 1
CO - Colombia 1
CU - Cuba 1
DJ - Gibuti 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
GN - Guinea 1
HN - Honduras 1
IE - Irlanda 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
ML - Mali 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
RW - Ruanda 1
VE - Venezuela 1
Totale 5.764
Città #
Singapore 263
Ashburn 252
Hong Kong 231
Hefei 177
Boardman 93
London 88
Beijing 83
Santa Clara 60
Shanghai 57
Rome 47
Dallas 35
Ho Chi Minh City 31
Munich 31
Los Angeles 30
San Francisco 29
Brno 21
São Paulo 21
Montreal 20
Buffalo 18
Pune 17
Council Bluffs 16
Washington 16
Hanoi 14
Toronto 14
Seattle 12
Amsterdam 11
Secaucus 10
Grumo Nevano 9
Brooklyn 8
Milan 8
Tokyo 7
Warsaw 7
Canberra 6
Chicago 6
Coral Springs 6
New York 6
Boston 5
Johannesburg 5
Mexico City 5
Paris 5
Stockholm 5
Catania 4
Guangzhou 4
Poplar 4
Rio de Janeiro 4
Santiago 4
Temecula 4
Turku 4
Charlotte 3
Cusano Milanino 3
Da Nang 3
Guayaquil 3
Melbourne 3
Montevideo 3
Mysore 3
Naples 3
Newark 3
Oklahoma City 3
Ribeirão Preto 3
Riyadh 3
Sonoma 3
Taipei 3
Thái Bình 3
Ankara 2
Anápolis 2
Atlanta 2
Baghdad 2
Belgrade 2
Belo Horizonte 2
Berlin 2
Brusaporto 2
Buford 2
Can Tho 2
Chennai 2
Chihuahua City 2
City of London 2
Cleveland 2
Cuautitlán Izcalli 2
Denver 2
Dubai 2
Edinburgh 2
Elk Grove Village 2
Ha Long 2
Haikou 2
Haiphong 2
Helsinki 2
Huế 2
Hyderabad 2
Linköping 2
Louisville 2
Ninh Bình 2
Novi Sad 2
Oslo 2
Phoenix 2
Porto Alegre 2
Quận Bình Thạnh 2
Quận Một 2
San Jose 2
Santo Domingo 2
Skopje 2
Totale 1.932
Nome #
Feasibility and efficacy of Letrozole in heavily pre-treated patients with relapsed ovarian cancer not eligible for further chemotherapy cycles 222
A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery 215
Efficacy of termoablative fractional CO2 laser (Monnalisa Touch) in stress urinary incontinence 208
Assessment of quality of life and urinary and sexual function after radical hysterectomy in long-term cervical cancer survivors 207
Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma 203
Intravesical Instillations of Hyaluronic Acid as First-Line Treatment in Patients with Interstitial Cystitis/Bladder Pain Syndrome: Use, Efficacy and Effects on Quality of Life 201
Does HE4 have a role as biomarker in the recurrence of ovarian cancer? 200
Does HE4 have a role in the recurrence of ovarian cancer? 188
Anterior colporrhaphy plus inside-out tension-free vaginal tape for associated stress urinary incontinence and cystocele: 10-year follow up results 188
Chemotherapy as adjuvant treatment for intermediate-high risk early-stage endometrial cancer a pilot study 175
Antiangiogenics and immunotherapies in cervical cancer: an update and future's view 175
Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer? 168
Early Mini-Invasive Treatment of Persistent Cervical Dysplasia: Clinical Outcome and Psycho-Relational Impact 112
A critical review on HE4 performance in endometrial cancer: where are we now? 112
An ultra-miniinvasive treatment for stress urinary incontinence in complicated older patients 110
Role of Protopine and Nuciferine in the Management of Nocturia, Urgency, and Dysuria in Pre- and Postmenopausal Women: A Prospective Pilot Study 104
Effectiveness of human epididymis protein 4 (HE4) as predictor of response to first line platinum based chemotherapy 99
Adjuvant chemotherapy after primary treatments for cervical cancer: a critical point of view and review of the literature 99
Bladder function after laparoscopic nerve-sparing radical hysterectomy 97
Does Extensive Upper Abdomen Surgery During Primary Cytoreduction Impact on Long-term Quality of Life? 96
A gastrointestinal stromal tumor presenting as a pelvic mass: A case report 95
A new type of absorbable barbed suture for use in laparoscopic myomectomy 95
C-reactive protein "at first sight": Standard postoperative trend in gynecological surgery and a comparative analysis with white blood cell levels 94
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 92
Implementing the Risk of Endometrial Malignancy Algorithm (REM) adding obesity as a predictive factor: Results of REM-B in a single-center survey 91
The use of sealing hemostat patch (HEMOPATCH®) in laparotomic myomectomy: a prospective case-control study 89
Aortic lymphadenectomy in cervical cancer: Anatomy, classification and technique 89
Pelvic-cutaneous fistula after retropubic vaginal tape placement 86
Long-term follow-up of bulking agents for stress urinary incontinence in older patients 83
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 82
Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? 64
Ureteral injuries management in gynaecologic surgery: the role of the conservative approach 49
The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer 46
METODO PER LA DETERMINAZIONE DI UN INDICE PREDITTIVO DEL RISCHIO DI TUMORE DELL’ENDOMETRIO 43
Surgical primary treatment of stage IVA cervical cancer: A multicentre retrospective study 40
Influence of pneumoperitoneum pressure on surgical field during robotic and laparoscopic surgery: a comparative study 39
Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study 38
The role of peritoneal lavage in benign gynecologic laparoscopic surgery 37
Old Issues and New Perspectives on Endometrial Cancer Therapy: How Molecular Characteristics Are Changing the Therapeutic Pathway 37
The Role of TAP/RS Block in Minor Gynecologic Laparoscopic Surgery: A Randomized Clinical Trial 37
Tension-free vaginal tape versus transobturator suburethral tape: Five-year follow-up results of a prospective, randomised trial 37
PROGNOSTIC FACTORS AND BYOCHEMISTRY IN PATIENTS WITH OVARIAN CANCER: A NEW CLINICAL MODEL OF PREDICTION 37
Ovarian cancer relapse: From the latest scientific evidence to the best practice 36
Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4 36
REM (Risk of Endometrial Malignancy): a proposal for a new scoring system to evaluate risk of endometrial malignancy 36
Sentinel lymph node in cervical cancer: a literature review on the use of conservative surgery techniques 36
Sacral neuromodulation after stabilization of L2-S1 vertebrae with metallic fixation devices: is it feasible? 34
The True Impact of Voiding Dysfunctions after Transobturator Sub-Urethral Tape Procedures: A Systematic Review of Literature 33
The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review 32
Quality of life in platinum-sensitive recurrent ovarian cancer: chemotherapy versus surgery plus chemotherapy 32
Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study 31
Effectiveness of CO2 laser on urogenital syndrome in women with a previous gynecological neoplasia: a multicentric study 30
Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset 30
Tailoring parametrectomy for early cervical cancer (Stage IA-IIA FIGO): a review on surgical, oncologic outcome and sexual function 30
The effects of giving patients verbal or written pre-operative information in gynecologic oncology surgery: a randomized study and the medical-legal point of view 30
Ten years of HPV vaccines: State of art and controversies 30
Real-time infrared thermography for ureter detection during hysterectomy 30
Update on lymphadenectomy in early and advanced ovarian cancer 29
Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature 29
Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial 29
Role of human epididymis protein 4 (HE4) in detecting recurrence in CA125 negative ovarian cancer patients 29
The role of novel biomarker HE4 in endometrial cancer: a case control prospective study 29
The role of macroplastique implantation in the management of occult urinary stress incontinence 28
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 27
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 27
The use of novel hemostatic sealant (Tisseel (R)) in laparoscopic myomectomy: a case-control study 26
Surgical treatment of rectovaginal endometriosis with extensive vaginal infiltration: results of a systematic three-step vagino-laparoscopic approach 26
Update on urodynamic bladder dysfunctions after radical hysterectomy for cervical cancer 26
Use of liposome encapsulated doxorubicin citrate (LEDC) as a valid drug in patients affected by ovarian cancer suffering from chemotherapy side-effects 25
Serous Tubal Intraepithelial Carcinoma (STIC): A Review of the Literature on the Incidence at the Time of Prophylactic Surgery 24
Use of Sensor Array Analysis to Detect Ovarian Cancer through Breath, Urine, and Blood: A Case-Control Study 24
Hormone replacement therapy in cancer survivors: Utopia? 24
The role of human epididymis protein 4 as a biomarker in gynecologic malignancies 24
Use of carboplatinum as neoadjuvant setting for patients affected by locally advanced cervical cancer 24
Learning curves of a resident surgeon performing transobturator tape procedures for stress urinary incontinence 23
Suburethral sling in autoimmune patients: complications, quality of life, and success rate 23
QUALITY OF LIFE IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: CHEMOTHERAPY VERSUS SURGERY PLUS CHEMOTHERAPY 21
Vaginectomy as treatment of isolated vaginal relapse (IVR) of gynecological neoplasms 21
Post-radical hysterectomy detrusor dysfunctions: is sacral neurostimulation a valid treatment strategy? 20
Total rectosigmoidectomy versus partial rectal resection in primary debulking surgery for advanced ovarian cancer 20
Surgical primary treatment of stage IVA cervical cancer: A multicenter retrospective study. 20
Success rates, quality of life, and feasibility of sacral nerve stimulation in elderly patients: 1-year follow-up 19
Use of carboplatinum as neoadjuvant setting for patients affected by locally advanced cervical cancer 19
The novel biomarker HE4 versus CA125 in detecting endometrial cancer: A case control prospective study 18
Quality of life in patients with endometrial cancer treated with or without systematic lymphadenectomy 18
IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancers 17
Tailored Treatment Strategies in First Line Therapy for Ovarian Cancer Patients: A Critical Review of the Literature 16
Reply from Authors re: Elisabetta Costantini, Massimo Lazzeri. Elephants Can Remember. Eur Urol 2010;58: 678-9 16
Continuous wound infusion as a valid alternative to tap block for postoperative analgesia after abdominal hysterectomy: A randomized controlled trial 13
Totale 5.799
Categoria #
all - tutte 40.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.104


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022131 0 0 9 0 0 0 0 4 1 4 0 113
2022/202345 0 1 1 0 1 1 10 2 2 3 16 8
2023/2024443 14 39 28 36 36 137 5 60 8 13 34 33
2024/20254.104 78 22 118 27 25 90 62 37 228 265 1.429 1.723
2025/20261.076 266 142 125 268 161 114 0 0 0 0 0 0
Totale 5.799